DLBS1425

· Dexa Medica Group

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DLBS1425, covering 2012-10-18 to 2013-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients [Phase 2, Phase 3]